Table 1 Ezetimibe preference in different patient profiles
From: Lipid management in India: a nationwide, cross-sectional physician survey
Patient profiles where ezetimibe is used | Number of respondents (%) |
|---|---|
Patients with uncontrolled LDL-C despite maximum-dose statin therapy | 107 (30.3) |
Statin-intolerant patients | 82 (23.2) |
Patients with LDL-C not controlled by moderate-dose statin therapy | 78 (22.1) |
As monotherapy when LDL-C is slightly above goal | 16 (4.5) |
Patients with high total cholesterol and LDL-C | 1 (0.3) |
Do not use ezetimibe in clinical practice | 119 (33.7) |
TOTAL | 353 |